Risk factors of positive surgical margin and biochemical recurrence of patients treated with radical prostatectomy: A single-center 10-year report

Chinese Medical Journal

Volumn 124, Issue 7, 2011, Pages 1001-1005

  Li, Kin ^a   Li, Hong ^a   Yang, Yong ^b   Lap Hong, Ian ^c   Wai Hong, Pun ^c   Son Fat, Ho ^c  

^a SICHUAN UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Macau Special Administrative Region   (China)

Author keywords

Biochemical recurrence; Complication; Positive surgical margin; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; ARTICLE; BLADDER NECK STENOSIS; BLEEDING; BLOOD LEVEL; CANCER GROWTH; CANCER STAGING; CYST; DISEASE SEVERITY; ERECTILE DYSFUNCTION; GLEASON SCORE; HUMAN; INCIDENCE; LAPAROSCOPIC SURGERY; LYMPHATIC CYST; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PERIOPERATIVE COMPLICATION; POSITIVE SURGICAL MARGIN; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PROSTATE; PROSTATE APEX; PROSTATE CANCER; PROSTATE LOBE; PROSTATECTOMY; RADICAL RETROPUBIC PROSTATECTOMY; RECTUM INJURY; RECURRENCE RISK; RISK FACTOR; SEMINAL VESICLE; STRESS INCONTINENCE; SURGICAL ANATOMY; SURGICAL MORTALITY; URINE LEAKAGE IN DRAINAGE; UROFLOWMETRY;

AGED; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 79954491315     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.07.009     Document Type: Article

References (21)

1. Xiang YB. An analysis of data utilization of high risk area for cancer in China. Bull Chin Cancer 2005; 14: 562-569.
2. Xu ZB, Wang GM, Sun LA, Zhang YK. The incidence of prostatic carcinoma in Shanghai. Chin J Clin Med (Chin) 2003; 10: 344-346.
3. Ian LH, Li H, Yang Y, Ho CF. Comparisons of randomly pathological biopsy and postoperative pathology of prostate between Chinese and Caucasian in Macau Special Administrative Region and their significances. Chin Med J 2008; 121: 292-294.
4. Department of Statistics Center of Health Government, Macau Special Administrative Region Demography. 2005. (Accessed at http://www.dsec.gov.mo/e_index.html)
5. Walsh PC, Garcia Jr JR. Radical retropubic prostatectomy: a detailed description of the surgical technique. A video presentation. (Accessed at http://urology.jhu.edu/2004)
6. Bhayani SB, Pavlovich CP, Strup SE, Dahl DM, Landman J, Fabrizio MD, et al. Laparoscopic radical prostatectomy: a multi-institutional study of conversion to open surgery. Urology 2004; 63: 99-102.
7. Collette L, van Poppel H, Bolla M, van Cangh P, Vekemans K, Pozzo LD, et al. Patients at high risk of progression after radical prostatectomy: do they all benefit from immediate post-operative irradiation? (EORTC trial 22911). Eur J Cancer 2005; 41: 2662-2672.
8. Schroder F, Hermanek P, Denis L. The TNM classification of prostate cancer. Prostate 1992; 4 Suppl: s129-s133.
9. Swindle PW, Kattan MW, Scardino PT. Markers and meaning of primary treatment failure. Urol Clin North Am 2003; 30: 377-401.
10. Simmons MN, Stephenson AJ, Klein EA. Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy. Eur Urol 2007; 51: 1175-1184.
11. Yang Y. Treatment of the positive surgical margin following radical prostatectomy. Chin Med J 2008; 12: 375-379.
12. Karakiewicz PI, Eastham JA, Graefen M, Cagiannos I, Stricker PD, Klein E, et al. Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients. Urology 2005; 66: 1245-1250.
13. Touijer K, Kuroiwa K, Eastham JA, Vickers A, Reuter VE, Scardino PT, et al. Risk-adjusted analysis of positive surgical margins following laparoscopic and retropubic radical prostatectomy. Eur Urol 2007; 52: 1090-1096.
14. Gettman MT, Blute ML. Radical prostatectomy: does surgical technique influence margin control? Urol Oncol 2010; 28: 219-225.
15. Bong GW, Ritenour CW, Osunkoya AO, Smith MT, Keane TE. Evaluation of modern pathological criteria for positive margins in radical prostatectomy specimens and their use for predicting biochemical recurrence. BJU Int 2009; 103: 327-331.
16. Pfitzenmaier J, Pahernik S, Tremmel T, Haferkamp A, Buse S, Hohenfellner M. Positive surgical margins after radicalprostatectomy: do they have an impact on biochemical or clinical progression? BJU Int 2008; 102: 1413-1418.
17. Guillonneau B, el-Fettouh H, Baumert H, Cathelineau X, Doublet JD, Fromont Q, et al. Laparoscopic radical prostatectomy: oncological evaluation after 1000 cases a Montsouris Institute. J Urol 2003; 169: 1261-1266.
18. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999; 281: 1591-1597.
19. Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 2005; 294: 433-439.
20. Uchio EM, Aslan M, Wells CK, Calderone J, Concato J. Impact of biochemical recurrence in prostate cancer among US veterans. Arch Intern Med 2010; 170: 1390-1395.
21. Salem S, Chang SS, Clark PE, Davis R, Herrell SD, Kordan Y, et al. Comparative analysis of whole mount processing and systematic sampling of radical prostatectomy specimens: pathological outcomes and risk of biochemical recurrence. J Urol 2010; 184: 1334-1340.